Hancock Whitney Corp Makes New Investment in Docusign Inc. $DOCU

Key Points

• Hancock Whitney Corp has acquired a new stake in Docusign Inc., purchasing 6,689 shares valued at approximately $544,000.
• Docusign's recent earnings report showed a quarterly EPS of $0.92, exceeding expectations, with revenue of $800.64 million, an 8.8% increase from the previous year.
• The company has initiated a $1 billion stock repurchase plan, signaling management's belief that its stock is undervalued.

Hancock Whitney Corp acquired a new stake in Docusign Inc. (NASDAQ:DOCU - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 6,689 shares of the company's stock, valued at approximately $544,000.

Several other institutional investors and hedge funds have also made changes to their positions in DOCU. Captrust Financial Advisors boosted its position in shares of Docusign by 8.8% during the 4th quarter. Captrust Financial Advisors now owns 41,989 shares of the company's stock worth $3,776,000 after acquiring an additional 3,402 shares in the last quarter. Cetera Investment Advisers raised its stake in shares of Docusign by 11.8% during the 4th quarter. Cetera Investment Advisers now owns 50,329 shares of the company's stock worth $4,527,000 after buying an additional 5,302 shares in the last quarter. CoreCap Advisors LLC grew its holdings in shares of Docusign by 113.4% in the 4th quarter. CoreCap Advisors LLC now owns 2,044 shares of the company's stock worth $184,000 after acquiring an additional 1,086 shares during the period. Deutsche Bank AG grew its holdings in shares of Docusign by 26.3% in the 4th quarter. Deutsche Bank AG now owns 546,078 shares of the company's stock worth $49,114,000 after acquiring an additional 113,608 shares during the period. Finally, Ethic Inc. acquired a new stake in shares of Docusign in the 4th quarter worth approximately $341,000. 77.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DOCU has been the topic of a number of analyst reports. Piper Sandler increased their target price on Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a report on Friday, September 5th. JMP Securities reiterated a "market outperform" rating and set a $124.00 target price on shares of Docusign in a report on Friday, September 5th. Evercore ISI raised their price objective on Docusign from $90.00 to $92.00 and gave the stock an "in-line" rating in a report on Friday, September 5th. Citigroup raised their price objective on Docusign from $110.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, September 4th. Finally, Zacks Research upgraded Docusign from a "hold" rating to a "strong-buy" rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have assigned a Hold rating to the stock. According to data from MarketBeat.com, Docusign presently has an average rating of "Hold" and a consensus price target of $94.14.

Docusign Stock Performance

Shares of NASDAQ DOCU traded up $1.45 during midday trading on Thursday, reaching $80.27. 2,463,495 shares of the company's stock were exchanged, compared to its average volume of 2,674,016. Docusign Inc. has a 52-week low of $55.14 and a 52-week high of $107.86. The stock has a market capitalization of $16.14 billion, a PE ratio of 60.30, a price-to-earnings-growth ratio of 4.18 and a beta of 1.02. The business's fifty day moving average price is $75.69 and its two-hundred day moving average price is $79.29.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. During the same period in the previous year, the firm posted $0.97 earnings per share. Docusign's quarterly revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Analysts predict that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Docusign declared that its board has authorized a share buyback program on Thursday, June 5th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to buy up to 6.6% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

Insider Transactions at Docusign

In other Docusign news, Director Teresa Briggs sold 534 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $74.37, for a total transaction of $39,713.58. Following the sale, the director directly owned 8,805 shares of the company's stock, valued at $654,827.85. The trade was a 5.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the sale, the chief executive officer directly owned 143,983 shares in the company, valued at approximately $11,160,122.33. This trade represents a 21.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 78,552 shares of company stock worth $5,983,631 in the last three months. 1.01% of the stock is currently owned by company insiders.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.